GLP-1 Market: Innovation and Competitive Landscape

adicionou um novo artigo Outro

2026-10-09 05:28:45 -

The GLP-1 Market is expanding as therapeutic applications move beyond diabetes into obesity and cardiovascular disease. Valued at USD 52.82 billion in 2025, the GLP-1 Market is projected to reach USD 58.48 billion in 2026 and USD 133.92 billion by 2034, growing at a CAGR of 10.9% during the forecast period 2026–2034. Key players include AstraZeneca, Boehringer Ingelheim, D&D...

0 Comentários 0 Compartilhamentos 11 Visualizações 0 Anterior